H. KARACA, "Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4, pp.1471-1477, 2015
KARACA, H. 2015. Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4 , 1471-1477.
KARACA, H., (2015). Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4, 1471-1477.
KARACA, Halit. "Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4, 1471-1477, 2015
KARACA, Halit. "Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4, pp.1471-1477, 2015
KARACA, H. (2015) . "Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.16, no.4, pp.1471-1477.
@article{article, author={Halit KARACA}, title={Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer.}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2015, pages={1471-1477} }